WebJun 25, 2024 · Oxurion NV Wouter Piepers, Global Head of Investor Relations & Corporate Communications Tel: +32 16 75 13 10 / +32 478 33 56 32 [email protected] WebApr 10, 2024 · RADNOR, PA / ACCESSWIRE / April 10, 2024 / BM Technologies, Inc. (NYSE American:BMTX), one of the largest digital banking platforms and Banking-as-a-Service (BaaS) providers, was selected as a winner in the 2024 FinTech Breakthrough Awards in the Best Banking Infrastructure Software award category. The Fintech Breakthrough Awards …
OXURION NV Presenting Scientific Data at ARVO 2024 Annual …
WebOxurion: We're developing next-generation ophthalmic therapies Your vision Your vision is our vision. Our vision Your vision is our vision. Our vision Your vision is our vision. Our vision Say Hello to... Pioneering Treatments for Diabetic Eye Disease Meet our team WebJun 30, 2024 · Investor Relations Corporate Profile Oxurion is a clinical stage biopharmaceutical company developing next generation standard of care ophthalmic therapies, which are designed to improve and better preserve vision in patients with retinal disorders including diabetic macular edema (DME). Financial Filings brita water pitcher xl
BM Technologies (NYSE:BMTX) Wins 2024 FinTech Breakthrough …
WebApr 12, 2024 · HOUSTON – ConocoPhillips is hosting an Analyst & Investor Meeting today to outline details of a compelling operating and financial plan that features durable returns and cash flow growth for decades to come, while further describing the company’s valued role in the energy transition. “Today I’m pleased to once again share a 10-year plan that provides … WebApr 14, 2024 · Oxurion received a transparency notification on April 12, 2024 from Atlas Special Opportunities LLC indicating that as of April 11, 2024, it held 26,728,439 shares of the then outstanding 632,659,186 shares, and therefore crossed above the threshold (3%) by virtue of acquisition of voting securities. ... Investor Relations: christian@borsveckan ... WebFeb 10, 2024 · Oxurion Receives Transparency Notifications Oxurion Receives Transparency Notifications. Leuven, BELGIUM, Boston, MA, US – February 10, 2024 – 7.30 PM CET Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with clinical stage assets in vascular … brita water purifier faucet